Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.870
+0.010 (0.54%)
May 28, 2026, 1:38 PM EDT - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $341.63 million as of May 28, 2026. Its market cap has increased by 205.00% in one year.
Market Cap
341.63M
Enterprise Value
212.28M
1-Year Change
205.00%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $341.63M, a decrease of -86.77%. That is a compound annual growth rate of -52.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 339.80M | 11.71% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 353.72M |
| Immuneering | 348.72M |
| Fennec Pharmaceuticals | 344.94M |
| Rezolute | 339.52M |
| YD Bio | 334.02M |
| REGENXBIO | 328.28M |
| Palisade Bio | 326.48M |
| Lineage Cell Therapeutics | 324.09M |